Consuming too much added sugar can increase the risk of chronic diseases such as Type 2 diabetes, heart disease, obesity, non-alcoholic fatty liver disease, high blood pressure and some cancers, ...

The enzyme aminocarboxymuconate semialdehyde decarboxylase (ACMSD) is a regulator of de novo NAD+ synthesis and is reduced in ...

Medically reviewed by Christopher Lee, MD Congestive heart failure (CHF), sometimes simply called heart failure, happens when ...

Using genetic tools, the scientists then blocked TYK2 in the mice with Alzheimer's. This resulted in a reduction in the ...

Researchers from Durham University, Jagiellonian University (Poland) and the John Innes Center have achieved a breakthrough ...

An enzyme called EZH2 has an unexpected role in driving aggressive tumor growth in treatment-resistant prostate cancers, ...

An enzyme called EZH2 has an unexpected role in driving aggressive tumor growth in treatment-resistant prostate cancers, ...

Researchers revealed new details of DNA gyrase, using high-resolution cryo-electron microscopy, paving the way for more ...

An enzyme called EZH2 has an unexpected role in driving aggressive tumor growth in ... of a protein called PKCλ/ι in prostate cancer cells enables EZH2 to drive aggressive growth, even with androgen ...

Researchers from the University of Washington are developing new antibiotics targeting bacterial methionyl-tRNA synthetase (MetRS). This enzyme is responsible for charging tRNA(met) with methionine ...

An enzyme called EZH2 has an unexpected role in driving aggressive tumor growth in treatment-resistant prostate cancers, according to a new study by scientists at Weill Cornell Medicine.